ZA200201301B - Medicaments that contain xenogenic oligo- or/and polyrinbonucleotides. - Google Patents

Medicaments that contain xenogenic oligo- or/and polyrinbonucleotides. Download PDF

Info

Publication number
ZA200201301B
ZA200201301B ZA200201301A ZA200201301A ZA200201301B ZA 200201301 B ZA200201301 B ZA 200201301B ZA 200201301 A ZA200201301 A ZA 200201301A ZA 200201301 A ZA200201301 A ZA 200201301A ZA 200201301 B ZA200201301 B ZA 200201301B
Authority
ZA
South Africa
Prior art keywords
medicament
oligo
polyribonucleotides
treatment
xenogeneic
Prior art date
Application number
ZA200201301A
Other languages
English (en)
Inventor
Hugo Seinfeld
Original Assignee
Hugo Seinfeld
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hugo Seinfeld filed Critical Hugo Seinfeld
Publication of ZA200201301B publication Critical patent/ZA200201301B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA200201301A 1999-08-27 2002-02-15 Medicaments that contain xenogenic oligo- or/and polyrinbonucleotides. ZA200201301B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19940748A DE19940748A1 (de) 1999-08-27 1999-08-27 Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide

Publications (1)

Publication Number Publication Date
ZA200201301B true ZA200201301B (en) 2002-11-27

Family

ID=7919851

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200201301A ZA200201301B (en) 1999-08-27 2002-02-15 Medicaments that contain xenogenic oligo- or/and polyrinbonucleotides.

Country Status (22)

Country Link
US (1) US20060069057A1 (ko)
EP (1) EP1206267B1 (ko)
JP (1) JP2003508442A (ko)
KR (1) KR100840804B1 (ko)
CN (1) CN1177591C (ko)
AT (1) ATE277622T1 (ko)
AU (1) AU774877B2 (ko)
BR (1) BR0013645A (ko)
CA (1) CA2382034A1 (ko)
CZ (1) CZ2002702A3 (ko)
DE (2) DE19940748A1 (ko)
ES (1) ES2230181T3 (ko)
HU (1) HUP0202888A3 (ko)
IL (1) IL148336A (ko)
MX (1) MXPA02001995A (ko)
NO (1) NO20020937D0 (ko)
NZ (1) NZ516943A (ko)
PL (1) PL197393B1 (ko)
PT (1) PT1206267E (ko)
RU (1) RU2270669C2 (ko)
WO (1) WO2001015704A1 (ko)
ZA (1) ZA200201301B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10131148A1 (de) * 2001-06-28 2003-01-16 I P L Internat Pharmaceutics L Xenogene Oligo- oder/und Polyribonukleotide als Mittel zur Behandlung von malignen Tumoren
US20120071543A1 (en) * 2010-05-14 2012-03-22 Carter Jacob L Formulations of diluted genetic material and methods for making same
US9603898B2 (en) 2011-03-23 2017-03-28 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
RU2620069C2 (ru) * 2014-06-26 2017-05-22 Аоварт Гмбх Вещество и способ модуляции пролиферации и дифференцировки регуляторных, стволовых и других соматических клеток

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2547696A1 (de) * 1975-10-24 1977-04-28 Beecham Group Ltd Antivirale substanz, verfahren zu ihrer herstellung und diese substanz enthaltende arzneipraeparate
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
DE2824411A1 (de) * 1978-06-03 1979-12-13 Boehringer Sohn Ingelheim Antiviral wirksame t-rna-praeparate
US4924624A (en) * 1987-10-22 1990-05-15 Temple University-Of The Commonwealth System Of Higher Education 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof
US5744166A (en) * 1989-02-25 1998-04-28 Danbiosyst Uk Limited Drug delivery compositions
US5512668A (en) * 1991-03-06 1996-04-30 Polish Academy Of Sciences Solid phase oligonucleotide synthesis using phospholane intermediates
RU2083221C1 (ru) * 1993-01-12 1997-07-10 Научно-исследовательский конструкторско-технологический институт биологически активных веществ Научно-производственного объединения "Вектор" Индуктор интерферона ридостин
WO1994015620A1 (en) * 1993-01-14 1994-07-21 Pharmagenics, Inc. Novel oligonucleotides modified with non-nucleotide bridging groups
FR2713487B1 (fr) * 1993-12-09 1996-02-02 Labo Life Solutions de type homéopathique contenant un acide nucléique utilisables notamment dans la prévention ou le traitement de maladies infectieuses ou de maladies impliquant le dysfonctionnement d'un gène.
DE4438918A1 (de) * 1994-11-04 1996-05-09 Hoechst Ag Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
US6353055B1 (en) * 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US5834443A (en) * 1996-05-21 1998-11-10 Masiello; Domenick J. Composition and method for treating herpes simplex
RU2123339C1 (ru) * 1996-06-18 1998-12-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Противовирусное средство
IN184589B (ko) * 1996-10-16 2000-09-09 Alza Corp

Also Published As

Publication number Publication date
BR0013645A (pt) 2002-05-07
DE19940748A1 (de) 2001-03-01
IL148336A (en) 2005-11-20
KR20020031596A (ko) 2002-05-02
PL353881A1 (en) 2003-12-01
NO20020937L (no) 2002-02-26
NO20020937D0 (no) 2002-02-26
IL148336A0 (en) 2002-09-12
AU2808101A (en) 2001-03-26
ES2230181T3 (es) 2005-05-01
RU2270669C2 (ru) 2006-02-27
ATE277622T1 (de) 2004-10-15
RU2002107675A (ru) 2004-01-10
HK1048263A1 (en) 2003-03-28
AU774877B2 (en) 2004-07-08
EP1206267B1 (de) 2004-09-29
CN1371282A (zh) 2002-09-25
PL197393B1 (pl) 2008-03-31
KR100840804B1 (ko) 2008-06-23
HUP0202888A3 (en) 2005-11-28
MXPA02001995A (es) 2002-09-25
CZ2002702A3 (cs) 2002-07-17
HUP0202888A2 (hu) 2002-12-28
DE50008024D1 (de) 2004-11-04
JP2003508442A (ja) 2003-03-04
NZ516943A (en) 2003-09-26
WO2001015704A1 (de) 2001-03-08
PT1206267E (pt) 2005-01-31
EP1206267A1 (de) 2002-05-22
US20060069057A1 (en) 2006-03-30
CA2382034A1 (en) 2001-03-08
CN1177591C (zh) 2004-12-01

Similar Documents

Publication Publication Date Title
CN101254212B (zh) 美洲大蠊提取物有效部位在制备治疗生殖器疱疹药物中的应用
US3737524A (en) Medicaments derived from nucleic acids,processes for their preparation and their use
CN1306964C (zh) 治疗和预防炎症性疾病的诱饵组合物
WO2020147532A1 (zh) 分离的赤红球菌细胞壁骨架在制备治疗人宫颈癌前病变的药物中的用途
CN104353058B (zh) 商陆抗病毒蛋白冻干粉复合剂及其制备方法
CN104083427B (zh) 防治禽流感的复方黄芪多糖颗粒
AU774877B2 (en) Medicaments that contain xenogenic oligo- or/and polyribonucleotides
EP0382551B1 (en) Prevention and treatment of herpes virus infections
CN110522762A (zh) 一种具有预防和治疗炎症的生物多糖及其应用
JPH0449242A (ja) 抗ヘルペス剤、動物用抗ヘルペス剤
JP2747293B2 (ja) 細菌感染に対する非特異的防御を刺激するための薬剤
CN117180262B (zh) 高良姜素在制备虾白斑综合征治疗药物中的应用
AU2002354738B2 (en) Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours
CN111212901A (zh) 蓝绿藻萃取物及其制备方法与用途
CA2558289C (en) Peptides for the treatment of herpes virus infections
CN116903762B (zh) 一种具有肠道黏膜屏障修复功能的褐藻多糖及其制备方法
CN102585024A (zh) 猫棒束孢粗多糖及其制备方法和应用
HK1048263B (en) Medicaments that contain xenogenic oligo-or/and polyribonucleotides
CN121868411A (zh) 一种提升线粒体活性和抗衰老的麦冬粉及其制备方法和应用
HK40027758B (zh) 分离的赤红球菌细胞壁骨架在制备治疗单纯疱疹和/或带状疱疹的药物中的用途
JP2019172597A (ja) ヘルペス感染症の治療剤及び／又は予防剤
EA008646B1 (ru) Иммуностимулирующее средство